IL17A and ulcerative colitis: Gallic acid, a major chemical component of QLX, was reported to inhibit NF‐κB expression and activation followed by down‐regulation of IL‐1, ILI‐6, IL‐12, IL‐17 and IL‐23, TGF‐β and TNF‐α expression in ulcerative colitis.40